Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver cytoprotection by prostaglandins

J Quiroga1, J Prieto

  • 1Department of Internal Medicine, University of Navarra School of Medicine, Pamplona, Spain.

Pharmacology & Therapeutics
|January 1, 1993
PubMed
Summary

The liver plays a key role in processing arachidonic acid metabolites. Prostaglandins (PGs) demonstrate significant cytoprotective effects in experimental liver injury models, suggesting therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying patients at increased risk of non-ventilator-associated pneumonia on admission to hospital: a pragmatic prognostic screening tool to trigger preventative action.

The Journal of hospital infection·2023
Same author

The use of finger foods in care settings: an integrative review.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2019
Same author

Risk factors associated with congenital defects that alter hearing or vision in children born in the city of Bogotá between 2002 and 2016.

International journal of pediatric otorhinolaryngology·2019
Same author

Risk Factors of Mortality After Liver Transplantation in Uruguay.

Transplantation proceedings·2018
Same author

Letters.

Journal of wound care·2016
Same author

[Is it necessary to prescribe antibiotics in impacted third molar surgical removal?: comparative study between prescribing patterns].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2016

Area of Science:

  • Biochemistry
  • Hepatology
  • Pharmacology

Background:

  • The liver is central to the metabolism and elimination of systemic arachidonic acid products.
  • Liver synthesis of arachidonate metabolites via cyclooxygenase, lipoxygenase, and cytochrome P450 pathways is established.
  • Leukotriene B4 and cysteinyl-leukotrienes are implicated as mediators of liver damage.

Purpose of the Study:

  • To review the role of arachidonate metabolites in liver disease.
  • To focus on the cytoprotective effects of prostaglandins (PGs) in experimental liver injury.
  • To analyze the clinical utility of PGs in liver disease.

Main Methods:

  • Review of literature on liver function and arachidonic acid cascade.
  • Analysis of experimental models of liver damage (ischemia-reperfusion, CCl4, LPS, viral hepatitis).
  • Evaluation of clinical evidence for prostaglandin use in fulminant hepatic failure and graft nonfunction.

Main Results:

  • Prostaglandins (PGE2, PGE1, PGI2, and analogs) show cytoprotective effects in various experimental liver injury models.
  • Mechanisms of prostaglandin-mediated liver cytoprotection are explored.
  • Clinical evidence for prostaglandin efficacy in acute liver failure and post-transplant complications is critically assessed.

Conclusions:

  • Arachidonate metabolites, particularly prostaglandins, play a significant role in liver pathophysiology.
  • Prostaglandins exhibit promising cytoprotective properties in experimental liver disease.
  • Further clinical investigation is warranted to establish the therapeutic value of prostaglandins in human liver conditions.

Related Experiment Videos